FEBRUARY 28, 2007
VOLUME 4 NO. 4

POLICY & POLITICS

New prenatal screening guidelines spark row

SOGC wants more genetic tests. MDs not screening ethically, critics charge


Accusations about biased counselling began flying almost before the ink was dry on the new guidelines on prenatal screening from the Society of Obstetricians and Gynaecologists of Canada (SOGC). The recommendations themselves, published in early February, are hardly groundbreaking — they essentially seek to apply existing best practices in genetic screening across the country — but the resulting media maelstrom has revealed a serious schism in the way medical geneticists think about the way physicians are counselling their pregnant patients.

BEHIND THE SCREEN
The SOGC is recommending that all pregnant women in Canada be offered the choice of having non-invasive prenatal genetic screening for fetal aneuploidy (including Down syndrome, trisomy 18 and other genetic abnormalities), and sets goals for better screening methods and guaranteed counselling for patients who choose to undergo screening. The difference between the new guidelines and the last set, from 2001, is relatively minimal; the 2001 guidelines said women should be offered screening if a counselling program was available in the area to help inform women about risk assessments and their options. The new guidelines recommend that all women be offered screening and counselling, in an effort by the SOGC to push the provinces to expand their programs.

Dr Sylvie Langlois, a Vancouver clinical geneticist and one of the authors of the SOGC's new guidelines, says patients and doctors alike need to consider all the choices available to them, from whether to have the screening done to possible termination of pregnancies. "It's a question of letting everyone have the choice," says Dr Langlois of increasing access to screening. "It's not a question of trying to have perfect babies. We are trying to provide couples with information about preparing for pregnancies with mental illnesses."

The option to undergo blood-test screening is important, explains Dr Langlois, because it can determine whether diagnostic tests may be appropriate to identify fetal aneuploidy, which can help prepare obstetricians and surgeons for potentially complicated deliveries. Up to half of children born with Down syndrome are also born with heart defects that may require urgent, highly specialized cardiac surgery. Duodenal atresia and duodenal stenosis are also associated with Down syndrome births. "Trisomy 18 can also cause problems in labour," says Dr Langlois, "and knowing it exists can influence an obstetrician's management of fetal distress."

The new guidelines also describe the minimum detection rate and maximum false-positive rate of screening tests that may be used. Improving the screening methodology should reduce the number of amniocentesis tests performed to just a fraction of the current figure, about 8%, with equal effectiveness at diagnosing abnormalities, notes Dr Langlois. (Amniocentesis is an invasive genetic test that results in the loss of approximately 0.6% of the fetuses examined, according to a recent literature review.) The new guidelines recommend offering amniocentesis before screening only to patients over 40 years old, whereas the previous guidelines had a cut-off age of 35.

NEUTRALITY AT ISSUE
Outspoken opponents of prenatal screening like the Canadian Down Syndrome Society (CDSS) and McGill bioethicist Dr Margaret Somerville have publicly stated the SOGC's recommendations will lead to more abortions (Dr Somerville has called genetic testing a "search and destroy mission") and amount to eugenics. These charges are firmly denied by Dr Langlois. But what really appears to be at issue is the extent to which physicians influence patients' decisions about whether they should request screening or prenatal genetic diagnostics.

"A critical component of this screening process is the context, the language and manner in which these conversations about the possibility of Down syndrome occur," said the CDSS in a release. "The CDSS is greatly concerned that information provided to parents be clear, accurate and unbiased." Doctors do not provide value-neutral counselling, it went on, and their failure to do so amounts to an implicit sanction of eugenics to eliminate fetuses with Down syndrome.

The questionable neutrality of counselling was confirmed by at least one of the medical geneticists who served as a reviewer for the new SOGC guidelines. "There is a problem with that," admits Dr David Chitayat, the head of the prenatal diagnosis and medical genetics program at Toronto's Mount Sinai Hospital. He acknowledges that many physicians do not provide non-directive counselling. "People are not educated on how to counsel," he said. "We as medical geneticists are trained to counsel and make sure it is non-directive, but other physicians often do not know how to do it and just tell patients what should be done." It's not uncommon nowadays for the responsibility for counselling to fall to family physicians.

FORTHCOMING EVIDENCE
A systematic review of the international literature on women's "decisional needs" in prenatal Down syndrome testing is nearing completion by a group of Laval University researchers. One of its conclusions, according to a preliminary analysis presented at the Canadian Cochrane Symposium in Ottawa on February 12, identifies a significant gap in the knowledge of health professionals when it comes to women's decision-making about genetic screening.

"Family physicians are not prepared to counsel patients on test results," says Dr Sylvie St-Jacques, one of the authors of the review, which will likely be submitted for publication in April this year. "Risk communication is geneticists' speciality." In addition, doctors often don't take enough time to thoroughly explain the tests and the results with their patients, she says.

One problem that's been made clear by the review, adds fellow author Dr Sonya Grenier, is that Canada badly needs an oversight body to check up on doctors who provide prenatal genetic screening.

DISSENT AND DISAGREEMENT
Criticism of biased counselling was roundly dismissed by Dr Langlois. "We know our counselling is non-directive because 50% of patients don't choose to be screened," she says of her own practice, where she provides counselling. Over the course of the past month, she says, two of her patients decided to go ahead with their pregnancies despite diagnoses of Down syndrome, after she counselled them. "We provide a balanced view of Down syndrome, and we give them information published by the Canadian Down Syndrome Society, in fact."

But that may not be enough, says Dr Chitayat. "I have a fear that even though there are brochures and lots of information, that most women are not being told about the choices. Patients can be quite confused and most doctors don't counsel by asking what they want. Many just tell them to get the blood test."

The optimal solution for Ontario — he declined to speak about other provinces, though he says many are similar — would be for the health ministry to let doctors bill for group counselling sessions. Genetic screening's complexity demands about an hour with each patient, notes Dr Chitayat, but one could just as easily counsel 20 patients during that hour. If the system were streamlined like that, Dr Chitayat says medical genetics experts would be able to provide superior counselling for all patients who chose to have prenatal screening, and family physicians without training and experience on the topic would be off the hook.

 

 

back to top of page

 

 

 

 
 
© Parkhurst Publishing Privacy Statement
Legal Terms of Use
Site created by Spin Design T.